Butler Says Drug Failure Puts Pressure on Lilly Revenue: Video

Aug. 17 (Bloomberg) — Tony Butler, an analyst at Barclays Capital, talks about Eli Lilly & Co.’s decision to stop development of one of two Alzheimer’s drug…